510(k) Report

FDA applicant

Cozart Bioscience, Ltd.

Oxfordshire Ox14 4ru, GB6 decisions2001–20040 recalls

FDA records 6 decisions for Cozart Bioscience, Ltd. (Oxfordshire Ox14 4ru, GB) from 2001 to 2004: 6 510(k) clearances. Most are in product codes DKZ (Enzyme Immunoassay, Amphetamine) and MKU (Enzyme Immunoassay, Nicotine And Nicotine…). Its devices cite 3 predicates, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Cozart Bioscience, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Cozart Bioscience, Ltd. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Cozart Bioscience, Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Cozart Bioscience, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report